mRNA-1273.222
1 clinical trial
1 abstract
1 indication
Indication
COVID-19Abstract
Comparative effectiveness of the bivalent COVID-19 mRNA vaccines, mRNA1273-222 and BNT162b2, in immunocompromised adults in the US.Org: VHN Consulting Inc, Veradigm,
Clinical trial
A Phase 1/2 Study of Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA VaccinesStatus: Completed, Estimated PCD: 2023-06-16